Evaluating the impact of alternative therapies on tamoxifen adherence in breast cancer patients
Official title: Pilot Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Run by Institut Claudius Regaud · NCT04740697 · Data updated 2026-11-12
This study is testing whether using alternative therapies helps breast cancer patients stick to their tamoxifen treatment better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Months and up |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Institut Claudius Regaud Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | February 12, 2021 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT04740697 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are being treated for hormone-dependent localized breast cancer with tamoxifen.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have conditions that hinder medical follow-up will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to assess how the use of alternative and complementary therapies affects adherence to tamoxifen treatment in patients with localized hormone-dependent breast cancer. It will involve 200 patients who have been on tamoxifen for 1 to 3 years and will be monitored for one day to gather real-life data on their treatment adherence. The study is conducted at a single center in France, focusing on the relationship between complementary therapies and medication compliance.
Why it matters
Potential benefit: If successful, this study could enhance treatment adherence among breast cancer patients, potentially improving their outcomes.
How similar studies have gone: While the specific approach of combining alternative therapies with tamoxifen adherence is novel, similar studies have shown that complementary therapies can positively influence treatment adherence in cancer care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years at entry into the study. 2. Patient treated for hormone-dependent localized breast cancer requiring adjuvant Hormonal Therapy (HT) with tamoxifen. 3. Patients treated with tamoxifen for a maximum of 1 to 3 years. 4. Patient affiliated with a Social Security system in France. 5. Patients who signed informed consent prior to inclusion in the study and prior to any specific study procedures. Exclusion Criteria: 1. Pregnant or breastfeeding women. 2. Any psychological, family, geographical or sociological condition that does not allow the medical follow-up and/or the procedures foreseen in the study protocol to be respected. 3. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Where it's running
-
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France Recruiting
Study contacts
- Study coordinator: Florence DALENC
- Email: dalenc.florence@iuct-oncopole.fr
- Phone: 05 31 15 51 04
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.